The Clinicopathological Significance of Epithelial Mesenchymal Transition Associated Protein Expression in Head and Neck Squamous Cell Carcinoma
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Epithelial mesenchymal transition (EMT) has an important role in invasion and metastasis of tumor cells. The purpose of this study was to evaluate the roles of EMT-associated proteins on progression and metastasis as a prognostic/predictive factor in curatively-resected (R0) head and neck squamous cell carcinoma (HNSCC). Methods: A total of 118 patients who received curative surgery for HNSCC at Inha University Hospital between January 1996 and December 2011 were included. We used protein immunohistochemistry to evaluate the expression of E-cadherin, vimentin, and EZH2 on tissue microarrays. Also, we reviewed all medical records and analyzed the relationship between the expression of EMT-associated proteins and prognosis. Results: The E-cadherin-negative group showed more moderate/poor differentiation of cancer cell type than the higher E-cadherin–expressing group (p=.016) and high EZH2 expression was significantly correlated with nodal metastasis (p=.012). Our results demonstrate a significant association between high expression of EZH2 and vimentin and presence of distant progression (p=.026). However, expression of E-cadherin, vimentin, and EZH2 was not significantly associated with overall survival. Conclusions: These findings suggest that an EMT-associated protein expression profile is correlated with aggressiveness of disease and prognosis, and could be a useful marker for determination of additional treatment in curatively-resected HNSCC patients.
Abstract
Background: Epithelial mesenchymal transition (EMT) has an important role in invasion and metastasis of tumor cells. The purpose of this study was to evaluate the roles of EMT-associated proteins on progression and metastasis as a prognostic/predictive factor in curatively-resected (R0) head and neck squamous cell carcinoma (HNSCC). Methods: A total of 118 patients who received curative surgery for HNSCC at Inha University Hospital between January 1996 and December 2011 were included. We used protein immunohistochemistry to evaluate the expression of E-cadherin, vimentin, and EZH2 on tissue microarrays. Also, we reviewed all medical records and analyzed the relationship between the expression of EMT-associated proteins and prognosis. Results: The E-cadherin-negative group showed more moderate/poor differentiation of cancer cell type than the higher E-cadherin–expressing group (p=.016) and high EZH2 expression was significantly correlated with nodal metastasis (p=.012). Our results demonstrate a significant association between high expression of EZH2 and vimentin and presence of distant progression (p=.026). However, expression of E-cadherin, vimentin, and EZH2 was not significantly associated with overall survival. Conclusions: These findings suggest that an EMT-associated protein expression profile is correlated with aggressiveness of disease and prognosis, and could be a useful marker for determination of additional treatment in curatively-resected HNSCC patients.
참고문헌 (20)
- Ferlay J, "Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008", Int J Cancer, 127, pp.2893~2917 (2010)
- Thiery JP, "Epithelial-mesenchymal transitions in development and disease", Cell, 139, pp.871~890 (2009)
- Thiery JP, "Epithelial-mesenchymal transitions in tumour progression", Nat Rev Cancer, 2, pp.442~454 (2002)
- Thiery JP, "Complex networks orchestrate epithelial-mesenchymal transitions", Nat Rev Mol Cell Biol, 7, pp.131~142 (2006)
- Wang C, "Polycomb group protein EZH2-mediated E-cadherin repression promotes metastasis of oral tongue squamous cell carcinoma", Mol Carcinog, 52, pp.229~236 (2013)
- Nijkamp MM, "Expression of E-cadherin and vimentin correlates with metastasis formation in head and neck squamous cell carcinoma patients", Radiother Oncol, 99, pp.344~348 (2011)
- Ueda G, "Aberrant expression of beta- and gamma-catenin is an independent prognostic marker in oral squamous cell carcinoma", Int J Oral Maxillofac Surg, 35, pp.356~361 (2006)
- Pyo SW, "Expression of E-cadherin, P-cadherin and N-cadherin in oral squamous cell carcinoma: correlation with the clinicopathologic features and patient outcome", J Craniomaxillofac Surg, 35, pp.1~9 (2007)
- 명나혜, "Loss of E-cadherin and Acquisition of Vimentin in Epithelial-Mesenchymal Transition are Noble Indicators of Uterine Cervix Cancer Progression", Journal of Pathology and Translational Medicine, 46(4), pp.341~348 (2012), 대한병리학회[DOI]
- 홍란, "The Differential Expressions of the Epithelial-Mesenchymal Transition Regulator, Slug and the Cell Adhesion Molecule, E-cadherin in Colorectal Adenocarcinoma", Journal of Pathology and Translational Medicine, 42(6), pp.351~357 (2008), 대한병리학회
- 김효진, "Alteration of the E-Cadherin", β-Catenin Complex Is an Independent Poor Prognostic Factor in Lung Adenocarcinoma, 2013, pp.47(1), 44~51[DOI]
- Tan J, "Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells", Genes Dev, 21, pp.1050~1063 (2007)
- Breuer RH, "Increased expression of the EZH2 polycomb group gene in BMI-1-positive neoplastic cells during bronchial carcinogenesis", Neoplasia, 6, pp.736~743 (2004)
- Bachmann IM, "EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast", J Clin Oncol, 24, pp.268~273 (2006)
- Weikert S, "Expression levels of the EZH2 polycomb transcriptional repressor correlate with aggressiveness and invasive potential of bladder carcinomas", Int J Mol Med, 16, pp.349~353 (2005)
- Holland D, "Activation of the enhancer of zeste homologue 2 gene by the human papillomavirus E7 oncoprotein", Cancer Res, 68, pp.9964~9972 (2008)
- Liu LK, "Upregulation of vimentin and aberrant expression of E-cadherin", beta-catenin complex in oral squamous cell carcinomas: correlation with the clinicopathological features and patient outcome, 2010, pp.23, 213~224
- Diniz-Freitas M, "Reduced E-cadherin expression is an indicator of unfavourable prognosis in oral squamous cell carcinoma", Oral Oncol, 42, pp.190~200 (2006)
- Liu M, "The histone methyltransferase EZH2 mediates tumor progression on the chick chorioallantoic membrane assay, a novel model of head and neck squamous cell carcinoma", Transl Oncol, 6, pp.273~281 (2013)
- Ukpo OC, "Lack of association of cadherin expression and histopathologic type, metastasis, or patient outcome in oropharyngeal squamous cell carcinoma: a tissue microarray study", Head Neck Pathol, 6, pp.38~47 (2012)